Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $53 | $317 | $317 | $264 | $22.0K | $11.0K |
| Gross profit | $0 | $0 | −$53 | −$317 | −$317 | −$264 | −$22.0K | −$11.0K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $975.7K | $281.2K | $309.5K | $574.1K | $369.0K | $745.9K | $4.1M | $3.2M |
| Operating income | −$2.1M | −$1.3M | −$1.9M | −$2.7M | −$2.0M | −$3.7M | −$9.7M | −$5.4M |
| EBITDA | −$2.1M | −$1.3M | −$1.9M | −$2.7M | −$2.0M | −$3.4M | −$9.7M | −$5.4M |
| Net income | −$2.1M | −$1.3M | −$2.1M | −$3.7M | −$2.1M | −$3.4M | −$9.5M | −$4.5M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.03 | -0.02 | -0.03 | -0.05 | -0.03 | -0.04 | -0.11 | -0.05 |
Annual figures · source: Financial Modeling Prep
RENOVACARE INC
No one on the platform currently holds RCAR.
No tracked institution reports a position in RCAR as of their last filing.
No one on the platform has traded RCAR yet.
| +0.00% |
| $4M |
| — |
| PARDPoniard Pharmaceuticals, Inc. | $0.00 | +0.00% | $150 | — |
| QBIOQ BioMed Inc. | $0.00 | -0.00% | $14509 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.